Please use this identifier to cite or link to this item:
http://repo.knmu.edu.ua/handle/123456789/18470Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Babak, Oleg | - |
| dc.contributor.author | Molodan, Volodymyr | - |
| dc.contributor.author | Lapshyna, Kateryna | - |
| dc.contributor.author | Prosolenko, Kostyantyn | - |
| dc.date.accessioned | 2017-12-04T07:09:31Z | - |
| dc.date.available | 2017-12-04T07:09:31Z | - |
| dc.date.issued | 2017 | - |
| dc.identifier.citation | Biomarkers usage in minimally invasive diagnosis of nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients /O. Y. Babak, V. I. Molodan, K. A. Lapshyna, K. O. Prosolenko // The New Armenian Medical Journal. – 2017. – Т. 11, № 2. – P. 46–51. | ru_RU |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/18470 | - |
| dc.description.abstract | Plasma CK-18 and FGF-21 levels are increased in patients with NASH and also associate with atherogenic dyslipidemia and impaired liver enzyme activity. Study plasma levels of CK-18 and FGF21 allows to establish the presence of NASH in patients with NAFLD. The findings suggest the possibility of using these biomarkers for minimally invasive screening diagnosis of NASH and represent the perspective of further research. | ru_RU |
| dc.language.iso | en_US | ru_RU |
| dc.subject | NAFLD | ru_RU |
| dc.subject | hypertension | ru_RU |
| dc.title | Biomarkers usage in minimally invasive diagnosis of nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients | ru_RU |
| dc.type | Article | ru_RU |
| Appears in Collections: | Наукові праці. Кафедра внутрішньої медицини № 1 | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| BioMARKERS.pdf | 407,09 kB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.